GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (UKEX:JNJ) » Definitions » Cyclically Adjusted Revenue per Share

Johnson & Johnson (UKEX:JNJ) Cyclically Adjusted Revenue per Share : ₴1,318.10 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Johnson & Johnson's adjusted revenue per share for the three months ended in Dec. 2023 was ₴349.992. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₴1,318.10 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Johnson & Johnson was 10.80% per year. The lowest was 3.30% per year. And the median was 7.90% per year.

As of today (2024-05-01), Johnson & Johnson's current stock price is ₴5947.00. Johnson & Johnson's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₴1,318.10. Johnson & Johnson's Cyclically Adjusted PS Ratio of today is 4.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Johnson & Johnson was 5.90. The lowest was 3.74. And the median was 4.81.


Johnson & Johnson Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted Revenue per Share Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,180.59 1,318.10

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,374.65 1,307.37 1,403.08 1,318.10 -

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted PS Ratio falls into.



Johnson & Johnson Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=349.992/129.4194*129.4194
=349.992

Current CPI (Dec. 2023) = 129.4194.

Johnson & Johnson Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 250.638 99.695 325.368
201406 269.779 100.560 347.204
201409 256.436 100.428 330.464
201412 255.467 99.070 333.729
201503 244.528 99.621 317.670
201506 251.587 100.684 323.391
201509 242.312 100.392 312.376
201512 252.980 99.792 328.086
201603 247.997 100.470 319.454
201606 263.083 101.688 334.828
201609 254.461 101.861 323.305
201612 260.377 101.863 330.816
201703 256.536 102.862 322.769
201706 273.320 103.349 342.266
201709 285.482 104.136 354.796
201712 292.940 104.011 364.501
201803 291.315 105.290 358.078
201806 304.449 106.317 370.606
201809 296.717 106.507 360.549
201812 297.562 105.998 363.312
201903 295.064 107.251 356.054
201906 303.837 108.070 363.862
201909 308.805 108.329 368.924
201912 308.727 108.420 368.523
202003 308.112 108.902 366.163
202006 273.607 108.767 325.558
202009 314.135 109.815 370.215
202012 334.753 109.897 394.220
202103 332.174 111.754 384.681
202106 347.064 114.631 391.837
202109 347.023 115.734 388.057
202112 145.406 117.630 159.980
202203 349.428 121.301 372.814
202206 358.101 125.017 370.712
202209 298.848 125.227 308.854
202212 298.918 125.222 308.938
202303 377.760 127.348 383.905
202306 386.730 128.729 388.805
202309 333.066 129.860 331.937
202312 349.992 129.419 349.992

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Johnson & Johnson  (UKEX:JNJ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5947.00/1318.1
=4.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Johnson & Johnson was 5.90. The lowest was 3.74. And the median was 4.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Johnson & Johnson Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (UKEX:JNJ) Business Description

Industry
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson (UKEX:JNJ) Headlines